PMC:7558914 / 18540-18853
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
444 | 38-56 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
445 | 165-177 | Chemical | denotes | azithromycin | MESH:D017963 |
458 | 238-247 | Disease | denotes | Andalusia | |
459 | 266-285 | Disease | denotes | respiratory illness | MESH:D012140 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T32 | 266-285 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T122 | 0-313 | Sentence | denotes | In our study, monotherapy with 400 mg hydroxychloroquine twice daily the first day followed by 200 mg twice daily from day 2 to day 5, alone and in combination with azithromycin, were the preferred recommended regimens among protocols in Andalusia for treating mild respiratory illness with clinical risk factors. |